SMAD7 and Hepatic fibrosis: Notably, recent mechanistic studies indicate that hydronidone ameliorate liver fibrosis by inhibiting HSCs activation through a mechanism involving Smad7‐mediated degradation of TGF‐β receptor I (TGFβRI).